Case Studies for Overcoming Challenges in Using Big Data in Cancer.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
14 04 2023
Historique:
received: 15 04 2022
revised: 29 07 2022
accepted: 06 12 2022
medline: 17 4 2023
pubmed: 11 1 2023
entrez: 10 1 2023
Statut: ppublish

Résumé

The analysis of big healthcare data has enormous potential as a tool for advancing oncology drug development and patient treatment, particularly in the context of precision medicine. However, there are challenges in organizing, sharing, integrating, and making these data readily accessible to the research community. This review presents five case studies illustrating various successful approaches to addressing such challenges. These efforts are CancerLinQ, the American Association for Cancer Research Project GENIE, Project Data Sphere, the National Cancer Institute Genomic Data Commons, and the Veterans Health Administration Clinical Data Initiative. Critical factors in the development of these systems include attention to the use of robust pipelines for data aggregation, common data models, data deidentification to enable multiple uses, integration of data collection into physician workflows, terminology standardization and attention to interoperability, extensive quality assurance and quality control activity, incorporation of multiple data types, and understanding how data resources can be best applied. By describing some of the emerging resources, we hope to inspire consideration of the secondary use of such data at the earliest possible step to ensure the proper sharing of data in order to generate insights that advance the understanding and the treatment of cancer.

Identifiants

pubmed: 36625851
pii: 712813
doi: 10.1158/0008-5472.CAN-22-1277
pmc: PMC10102839
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1183-1190

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

Oncologist. 2015 May;20(5):464-e20
pubmed: 25876994
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Trends Genet. 2019 Mar;35(3):223-234
pubmed: 30691868
JCO Clin Cancer Inform. 2020 Oct;4:929-937
pubmed: 33104389
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:429-453
pubmed: 29400986
Cancer Res. 2023 Apr 14;83(8):1175-1182
pubmed: 36625843
Nat Commun. 2021 Feb 22;12(1):1226
pubmed: 33619257
Nat Genet. 2021 Mar;53(3):257-262
pubmed: 33619384
N Engl J Med. 2017 Mar 23;376(12):1178-1181
pubmed: 28328337
Clin Pharmacol Ther. 2017 May;101(5):619-621
pubmed: 28187513
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Lancet Oncol. 2017 Jan;18(1):132-142
pubmed: 27864015
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
JCO Clin Cancer Inform. 2018 Dec;2:1-14
pubmed: 30652542
JCO Clin Cancer Inform. 2017 Nov;1:1-15
pubmed: 30657384
Blood. 2017 Jul 27;130(4):453-459
pubmed: 28600341
Cancer Res. 2017 Nov 1;77(21):e15-e18
pubmed: 29092930
Cancer Discov. 2020 Apr;10(4):526-535
pubmed: 31924700
J Clin Epidemiol. 2016 Feb;70:214-23
pubmed: 26441289
Health Aff (Millwood). 2014 Jul;33(7):1203-11
pubmed: 25006147
Semin Oncol. 2019 Aug - Oct;46(4-5):314-320
pubmed: 31629530
J Clin Oncol. 2014 Aug 1;32(22):2373-9
pubmed: 24912897
Lancet Oncol. 2017 Jan;18(1):143-154
pubmed: 27979599

Auteurs

Shawn M Sweeney (SM)

American Association for Cancer Research, Philadelphia, Pennsylvania.

Natalie Abrams (N)

Division of Cancer Prevention, Early Detection Research Network, National Cancer Institute, Rockville, Maryland.

Stacey J Adam (SJ)

Foundation for the National Institutes of Health, Bethesda, Maryland.

Sara Brenner (S)

Office of In Vitro Diagnostics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland.

Dana E Connors (DE)

Foundation for the National Institutes of Health, Bethesda, Maryland.

Gerard J Davis (GJ)

Abbott Diagnostics Division, Abbott Laboratories, Lake Forest, Illinois.

Louis D Fiore (LD)

Boston University School of Medicine, Boston and New England Department of Veterans Affairs, Bedford, Massachusetts.

Susan H Gawel (SH)

Abbott Diagnostics Division, Abbott Laboratories, Lake Forest, Illinois.

Robert L Grossman (RL)

Center for Translational Data Science, The University of Chicago, Chicago, Illinois.

Sean E Hanlon (SE)

Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland.

Karl Hsu (K)

Sanofi, Bridgewater, New Jersey.

Gary J Kelloff (GJ)

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

Ilan R Kirsch (IR)

Adaptive Biotechnologies, Seattle, Washington.

Bill Louv (B)

Project Data Sphere, Morrisville, North Carolina.

Deven McGraw (D)

Ciitizen Platform at Invitae, San Francisco, California.

Frank Meng (F)

Boston University and Veterans Administration Boston Healthcare System, Boston, Massachusetts.

Daniel Milgram (D)

CCS Associates, San Jose, California.

Robert S Miller (RS)

CancerLinQ, American Society of Clinical Oncology, Alexandria, Virginia.

Emily Morgan (E)

Foundation for the National Institutes of Health, Bethesda, Maryland.

Lata Mukundan (L)

CCS Associates, San Jose, California.

Wendy S Rubinstein (WS)

Office of In Vitro Diagnostics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland.

Liz Salmi (L)

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Teilo H Schaller (TH)

Project Data Sphere, Morrisville, North Carolina.

George Shi (G)

Abbott Diagnostics Division, Abbott Laboratories, Lake Forest, Illinois.

Caroline C Sigman (CC)

Boston University and Veterans Administration Boston Healthcare System, Boston, Massachusetts.

Sudhir Srivastava (S)

Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH